Publications ICD-coded information on sites of metastasis in oncology real-world data is specific but not sensitive May 19, 2018 Parrinello, C.M., Seidl-Rathkopf, K.N., Bennette, C, Bourla, A.B., Nussbaum, N.C., Carson, K.R., Abernethy, A.P. ISPOR Annual Meeting. . https://4076230.fs1.hubspotusercontent-na1.net/hubfs/4076230/flatiron-com-pdf/Sites-of-Mets-Structured-vs-Unstructured-ISPOR-2018-Poster_Vertical_Final_MM.pdf Authors: Sources:ISPOR Annual Meeting Read the research Share More publicationsAugust 2026Real-world treatment duration and outcomes among patients with early-stage NSCLC receiving adjuvant osimertinib: a retrospective cohort studyAugust 2026Genomic alterations without approved 1L targeted therapies in patients with NSCLC PD-L1 ≥50% treated with immunotherapyAugust 2026Real-world outcomes with chemoradiation and durvalumab consolidation in stage III KRAS G12C-mutant NSCLC in the US
August 2026Real-world treatment duration and outcomes among patients with early-stage NSCLC receiving adjuvant osimertinib: a retrospective cohort study
August 2026Genomic alterations without approved 1L targeted therapies in patients with NSCLC PD-L1 ≥50% treated with immunotherapy
August 2026Real-world outcomes with chemoradiation and durvalumab consolidation in stage III KRAS G12C-mutant NSCLC in the US